- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07570095
Hyaluronic Acid Injection Combined With Rehabilitation for Frozen Shoulder (HA - AC)
Clinical Outcomes of Ultrasound-Guided Intra-Articular Hyaluronic Acid Injection Combined With Rehabilitation in Adhesive Capsulitis: A Randomized Controlled Trial
This randomized controlled trial evaluates the clinical efficacy of ultrasound-guided intra-articular hyaluronic acid injection combined with rehabilitation in patients with adhesive capsulitis (frozen shoulder).
Participants were randomly assigned to either an injection plus rehabilitation group or a rehabilitation-only group. The injection group received ultrasound-guided intra-articular hyaluronic acid once weekly for three weeks, along with a standardized rehabilitation program for six weeks. The control group received the same rehabilitation program without injection.
Clinical outcomes were assessed at multiple time points, including baseline, 4, 6, 8, and 12 weeks. The primary outcome was the change in the Shoulder Pain and Disability Index (SPADI) total score. Secondary outcomes included SPADI pain and disability subscales, as well as shoulder range of motion.
The trial was registered retrospectively at ClinicalTrials.gov (NCT07570095) after study completion due to administrative oversight.
The study was conducted in accordance with the protocol approved by the Tri-Service General Hospital Institutional Review Board (approval no. C202205160) prior to enrollment. The IRB-approved protocol specified the eligibility criteria and outcome measures reported in this record; discrepancies in the initial registry entry have been corrected in this amendment.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Adhesive capsulitis is a common musculoskeletal disorder characterized by progressive pain and restricted range of motion of the shoulder joint, leading to significant functional impairment. Although rehabilitation remains the cornerstone of treatment, the additional benefit of intra-articular hyaluronic acid injection remains controversial.
This randomized controlled trial aimed to evaluate the clinical efficacy of ultrasound-guided intra-articular injection of non-cross-linked hyaluronic acid combined with a structured rehabilitation program in patients with adhesive capsulitis.
Participants were randomly assigned to two groups: an injection plus rehabilitation group and a rehabilitation-only group. The injection group received ultrasound-guided intra-articular hyaluronic acid injections once weekly for three consecutive weeks. Both groups underwent a standardized rehabilitation program twice weekly for six weeks, including range of motion exercises, stretching, and strengthening under the supervision of a physical therapist.
Clinical outcomes were assessed at multiple time points, including baseline, 4, 6, 8, and 12 weeks. The primary outcome measure was the change in the Shoulder Pain and Disability Index (SPADI) total score over time. Secondary outcomes included SPADI pain and disability subscales, as well as shoulder external rotation range of motion.
The trial was registered retrospectively at ClinicalTrials.gov (NCT07570095) after study completion due to administrative oversight.
The study was conducted in accordance with the protocol approved by the Tri-Service General Hospital Institutional Review Board (approval no. C202205160) prior to enrollment. The IRB-approved protocol specified the eligibility criteria and outcome measures reported in this record; discrepancies in the initial registry entry have been corrected in this amendment.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Taipei
-
Taipei, Taipei, Taiwan, 114
- Tri-Service General Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Adults aged 40 to 70 years.
- Clinical diagnosis of frozen-phase primary adhesive capsulitis characterized by predominant stiffness as the chief complaint, with symptom duration of at least 3 months, minimal resting pain, and absence of nocturnal pain.
- Limitation of both active and passive shoulder range of motion, particularly in external rotation.
- Ability to understand the study procedures and provide informed consent.
Exclusion Criteria:
- Prior shoulder surgery or fracture on the affected side.
- Rotator cuff tear confirmed by imaging.
- Glenohumeral osteoarthritis or inflammatory joint disease.
- Neurological disorders affecting shoulder function.
- Previous intra-articular injection within the past 3 months.
- Contraindications to hyaluronic acid injection.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Hyaluronic Acid Injection + Rehabilitation
Participants receive ultrasound-guided intra-articular injection of non-cross-linked hyaluronic acid (10 mg/mL, once weekly for 3 consecutive weeks) combined with a standardized rehabilitation program consisting of joint mobilization, stretching, and strengthening exercises, performed twice weekly for 6 weeks.
|
Non-cross-linked hyaluronic acid (10 mg/mL) administered via ultrasound-guided intra-articular injection into the affected shoulder joint once weekly for 3 weeks.
Supervised physical therapy program including joint mobilization, stretching, and strengthening exercises, conducted twice weekly for 6 weeks.
|
|
Aktiv komparator: Rehabilitation Alone
Participants receive a standardized rehabilitation program including joint mobilization, stretching, and strengthening exercises, performed twice weekly for 6 weeks without hyaluronic acid injection.
|
Supervised physical therapy program including joint mobilization, stretching, and strengthening exercises, conducted twice weekly for 6 weeks.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Shoulder Pain and Disability Index (SPADI) Total Score
Tidsramme: Baseline, 4 weeks, 6 weeks, 8 weeks, and 12 weeks
|
The SPADI is a validated questionnaire assessing shoulder pain and functional disability, with total scores ranging from 0 to 100.
Higher scores indicate greater impairment.
|
Baseline, 4 weeks, 6 weeks, 8 weeks, and 12 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
SPADI Item - Wearing a Pullover Shirt
Tidsramme: Baseline, 4, 6, 8, and 12 weeks
|
Item-level SPADI score for wearing a pullover shirt (requires combined abduction and external rotation), rated 0-10 (0=no difficulty, 10=worst difficulty).
|
Baseline, 4, 6, 8, and 12 weeks
|
|
SPADI Item - Putting on Pants or Shorts
Tidsramme: Time Frame: Baseline, 4, 6, 8, and 12 weeks
|
Item-level SPADI score for putting on pants or shorts (requires internal rotation and extension), rated 0-10.
|
Time Frame: Baseline, 4, 6, 8, and 12 weeks
|
|
SPADI Item - Pain on Arm Traction
Tidsramme: Time Frame: Baseline, 4, 6, 8, and 12 weeks
|
Item-level SPADI pain score during arm traction of the affected side (reflects capsular tension), rated 0-10.
|
Time Frame: Baseline, 4, 6, 8, and 12 weeks
|
|
Shoulder Range of Motion
Tidsramme: Baseline, 4, 6, 8, and 12 weeks
|
Active and passive range of motion of the shoulder (flexion, abduction, external rotation) measured by gravity goniometer by a blinded assessor.
|
Baseline, 4, 6, 8, and 12 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- C202205160
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Klæbende kapsulitis
-
National Taiwan University Hospital Hsin-Chu BranchAfsluttet
-
Superior UniversityAktiv, ikke rekrutterendeAdhæsive Capsulitis, SkulderPakistan
-
Singapore General HospitalAfsluttet
-
DigitalRehabIkke rekrutterer endnuProteser | Adhæsive Capsulitis, Skulder | Skulder bageste ustabilitet | Skulder anterior ustabilitet | Skulder anterior latarjet ustabilitetItalien
-
Universidade do PortoIkke rekrutterer endnuSkuldersmerter | Klæbende kapsulitis | Frossen skulder | Skulderstivhed | Klæbende kapsulitis af uspecificeret skulder | Adhæsive Capsulitis, SkulderPortugal
-
Ondokuz Mayıs UniversityAfsluttetKinesiofobi | Adhæsive Capsulitis og Frozen Shoulder Syndrome | Pericapsular nervegruppeblok (PENG-blok)Kalkun
-
Issa, Abdulhamid Sayed, M.D.AfsluttetSkulderimpingementsyndrom | Rotator Cuff Tendinopati | Adhæsive Capsulitis og Frozen Shoulder SyndromeSyrien Arabiske Republik
Kliniske forsøg med Hyaluronic Acid (HA)
-
i+Med S.Coop.Dr. Goya Análisis, SL.Afsluttet
-
National Cancer Centre, SingaporeSingapore General Hospital; Singhealth Duke-NUS Oncology Academic Clinical...Afsluttet
-
Ospedale Policlinico San MartinoUniversita degli Studi di Genova; IRCSS Istituto Dermopatico dell'Immacolata...AfsluttetDiabetisk fodsår | PRP | Allogen | HudlæsionerItalien
-
Galderma R&DAfsluttetAnsigtsvævsforstørrelseSverige
-
Dr. Falk Pharma GmbHIkke rekrutterer endnuUndersøgelse med Norucholic Acid -tabletter hos patienter med primær skleroserende cholangitis (PSC)Primær skleroserende kolangitis
-
Universitätsklinikum Hamburg-EppendorfRekruttering
-
Suez Canal UniversityAfsluttet
-
University Hospitals, LeicesterJafron Biomedical Company LimitedRekrutteringBetændelse | Akut nyreskade | ARDS | Ekstrakorporal cirkulation; KomplikationerDet Forenede Kongerige
-
Medy-ToxAfsluttetNasolabial foldKorea, Republikken
-
TauTona GroupAfsluttet